Ausgabe 2/2011
Inhalt (37 Artikel)
Adherence to oral endocrine treatments in women with breast cancer: can it be improved?
Sheila A. Doggrell
Pregnancy after breast cancer: if you wish, ma’am
Olivia Pagani, Ann Partridge, Larissa Korde, Sunil Badve, John Bartlett, Kathy Albain, Richard Gelber, Aron Goldhirsch
Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression
Mei Kim Ang, Aik Seng Ooi, Aye Aye Thike, Patrick Tan, Zhongfa Zhang, Karl Dykema, Kyle Furge, Bin Tean Teh, Puay Hoon Tan
Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces α9-nicotinic acetylcholine receptor expression in human breast cancer cells
Chia-Hwa Lee, Ya-Chieh Chang, Ching-Shyang Chen, Shih-Hsin Tu, Ying-Jan Wang, Li-Ching Chen, Yu-Jia Chang, Po-Li Wei, Hui-Wen Chang, Chien-Hsi Chang, Ching-Shui Huang, Chih-Hsiung Wu, Yuan-Soon Ho
Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue
Sibyll Hein, Volkmar Müller, Nadine Köhler, Harriet Wikman, Sylke Krenkel, Thomas Streichert, Michaela Schweizer, Sabine Riethdorf, Volker Assmann, Maike Ihnen, Katrin Beck, Rana Issa, Fritz Jänicke, Klaus Pantel, Karin Milde-Langosch
Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ
Dana K. Furstenau, Nandita Mitra, Fei Wan, Robert Lewis, Michael D. Feldman, Douglas L. Fraker, Marina A. Guvakova
Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation
Chunjie Wang, Danh Tran-Thanh, Juan C. Moreno, Thomas R. Cawthorn, Lindsay M. Jacks, Dong-Yu Wang, David R. McCready, Susan J. Done
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells
Caroline Brünner-Kubath, Waheed Shabbir, Victoria Saferding, Renate Wagner, Christian F. Singer, Peter Valent, Walter Berger, Brigitte Marian, Christoph C. Zielinski, Michael Grusch, Thomas W. Grunt
Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients
Patricia Marino, Carole Siani, François Bertucci, Henri Roche, Anne-Laure Martin, Patrice Viens, Valérie Seror
Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells
Eugene P. Toy, Tiffany Lamb, Masoud Azodi, William J. Roy, Ho-Hyung Woo, Setsuko K. Chambers
Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features
Gulnur Guler, Cigdem Himmetoglu, Rafael E. Jimenez, Susan M. Geyer, Wenle P. Wang, Stefan Costinean, Robert T. Pilarski, Carl Morrison, Dinc Suren, Jianhua Liu, Jingchun Chen, Jyoti Kamal, Charles L. Shapiro, Kay Huebner
Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma
Paola Maroni, Emanuela Matteucci, Alessandro Luzzati, Giuseppe Perrucchini, Paola Bendinelli, Maria Alfonsina Desiderio
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients
Antonio Giordano, Mario Giuliano, Michelino De Laurentiis, Antonio Eleuteri, Francesco Iorio, Roberto Tagliaferri, Gabriel N. Hortobagyi, Lajos Pusztai, Sabino De Placido, Kenneth Hess, Massimo Cristofanilli, James M. Reuben
Surgery of the primary tumor does not improve survival in stage IV breast cancer
Laura Dominici, Julie Najita, Melissa Hughes, Joyce Niland, Paul Marcom, Yu-ning Wong, Bradford Carter, Sara Javid, Stephen Edge, Harold Burstein, Mehra Golshan
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer
C. K. Lee, M. Hudson, M. Stockler, A. S. Coates, S. Ackland, V. Gebski, S. Lord, M. Friedlander, F. Boyle, R. J. Simes
Bulky DNA adducts and breast cancer risk in the prospective EPIC-Italy study
Calogero Saieva, Marco Peluso, Giovanna Masala, Armelle Munnia, Marco Ceroti, Sara Piro, Francesco Sera, Benedetta Bendinelli, Valeria Pala, Sabina Sieri, Rosario Tumino, Maria Concetta Giurdanella, Salvatore Panico, Amalia Mattiello, Paolo Vineis, Silvia Polidoro, Giuseppe Matullo, Domenico Palli
Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study
Adriana Villaseñor, Anita Ambs, Rachel Ballard-Barbash, Kathy B. Baumgartner, Anne McTiernan, Cornelia M. Ulrich, Marian L. Neuhouser
Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007)
Mellissa Yong, Annette Østergaard Jensen, Jacob Bonde Jacobsen, Mette Nørgaard, Jon P. Fryzek, Henrik Toft Sørensen
Adipose levels of polybrominated diphenyl ethers and risk of breast cancer
Susan Hurley, Peggy Reynolds, Debbie Goldberg, David O. Nelson, Stefanie S. Jeffrey, Myrto Petreas
Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study
Jeanne S. Mandelblatt, Gheorghe Luta, Marilyn L. Kwan, Solomon B. Makgoeng, Isaac J. Ergas, Janise M. Roh, Barbara Sternfeld, Lucile L. Adams-Campbell, Lawrence H. Kushi
Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States
Martha L. Slattery, Kathy B. Baumgartner, Anna R. Giuliano, Tim Byers, Jennifer S. Herrick, Roger K. Wolff
The use of atypical antipsychotics and the risk of breast cancer
Laurent Azoulay, Hui Yin, Christel Renoux, Samy Suissa
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
Patricia A. Ganz, Laurel A. Habel, Erin K. Weltzien, Bette J. Caan, Steven W. Cole
Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: Effects of oral contraceptive use and parental origin of mutation
Shiri Bernholtz, Yael Laitman, Bella Kaufman, Shani Paluch Shimon, Eitan Friedman
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study
Shannon M. Conroy, Gertraud Maskarinec, Lynne R. Wilkens, Kami K. White, Brian E. Henderson, Laurence N. Kolonel
Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients
Samuel F. Gilbert, Amr S. Soliman, Maria Iniesta, Mohab Eissa, Ahmed Hablas, Ibrahim A. Seifeldin, Ashley Strahley, Mousumi Banerjee, Sofia D. Merajver
The relationship between bone mineral density and mammographic density in Korean women: The Healthy Twin study
Joohon Sung, Yun-Mi Song, Jennifer Stone, Kayoung Lee
Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes
Sarah J. Nyante, Marilie D. Gammon, Jay S. Kaufman, Jeannette T. Bensen, Dan Yu Lin, Jill S. Barnholtz-Sloan, Yijuan Hu, Qianchuan He, Jingchun Luo, Robert C. Millikan
Biologic markers determine both the risk and the timing of recurrence in breast cancer
Laura J. Esserman, Dan H. Moore, Pamela J. Tsing, Philip W. Chu, Christina Yau, Elissa Ozanne, Robert E. Chung, Vickram J. Tandon, John W. Park, Frederick L. Baehner, Stig Kreps, Andrew N. J. Tutt, Cheryl E. Gillett, Christopher C. Benz
Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer
Kristen N. Stevens, Xianshu Wang, Zachary Fredericksen, V. Shane Pankratz, James Cerhan, Celine M. Vachon, Janet E. Olson, Fergus J. Couch
Simultaneous measurement of ERα, HER2, and PhosphoERK1/2 in breast cancer cell lines by flow cytometry
Ulas Darda Bayraktar, Tae Kon Kim, Katherine Drews-Elger, Cara Benjamin, Dorraya El-Ashry, Eric Wieder, Krishna V. Komanduri
Two patients with germline mutations in both BRCA1 and BRCA2 discovered unintentionally: a case series and discussion of BRCA testing modalities
Ann Marie Augustyn, Nicole M. Agostino, Tara L. Namey, Suresh Nair, Martin A. Martino
PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression
Kevin Kalinsky, Adriana Heguy, Umeshkumar K. Bhanot, Sujata Patil, Mary Ellen Moynahan
Association between two polymorphisms of CD166/ALCAM gene and breast cancer risk in Chinese women
Qinglong Li, Feng Xu
Need for clarification of data in the recent meta-analysis about RAD51 135G>C polymorphism and breast cancer risk
Xiao-Feng He, Jiao Su, Ying Zhang, Da-Peng Ding, Wei Wang, Yi Liu
Association of XPC polymorphisms with breast cancer risk
Feng Xu, Dewu Zhong, Zhonghua Tang, Meirong Zhou, Yu Zhu